Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin, Administered Using Stereotactic Injection to the Striatum of Patients With Bilateral, Idiopathic Parkinson's Disease.

Next Previous
X
Search
Trial Profile

A Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin, Administered Using Stereotactic Injection to the Striatum of Patients With Bilateral, Idiopathic Parkinson's Disease.

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 27 Jun 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AXO Lenti PD (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; First in man; Therapeutic Use
  • Sponsors Oxford BioMedica

    • Most Recent Events

    • 25 Oct 2018 According to an Axovant Sciences media release, updated data from the study has been presented at the Annual Congress of the European Society of Gene and Cell Therapy and published in Human Gene Therapy, Clinical Development.
    • 09 Oct 2018 According to an Oxford BioMedica media release, data from this study to be Presented at the Annual Congress of the European Society.
    • 17 Mar 2017 According to an Oxford BioMedica media release, follow-up data from the study has been presented in May 2016 at the Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top